简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2016-11-28 17:38 NINLARO™ (ixazomib) Receives Conditional Approval from the European Commission to Treat Multiple Myeloma
2016-11-23 13:26 Provata Health Launches Groundbreaking Virtual Reality Guided Meditation App
2016-11-17 10:51 On World Prematurity Day, UNICEF emphasizes use of cost-effective interventions to improve survival of premature and low-birthweight babies
2016-11-17 10:09 Boehringer Ingelheim bevacizumab biosimilar candidate demonstrates bioequivalence to Avastin®
2016-11-17 10:05 Boehringer Ingelheim welcomes central role of LAMA/LABA therapy within 2017 GOLD Strategy for COPD
2016-11-16 17:28 Gore Global Registry for Endovascular Aortic Treatment Completes Enrollment
2016-11-16 17:18 Updated Phase III Results Reinforce Safety and Efficacy of Praxbind® (idarucizumab) in Urgent Situations
2016-11-15 17:57 Bioventus Expands to Mexico with DUROLANE® for Knee Osteoarthritis Patients
2016-11-15 15:49 MetLife Hong Kong Launches Unique Overseas Medical Treatment Insurance Plan
2016-11-15 14:35 New landmark study reveals adults with diabetes at unnecessary risk of vision loss
2016-11-15 10:02 Data on Early Onset of Efficacy for Oral OTEZLA® (apremilast) in Active Psoriatic Arthritis Presented at American College of Rheumatology
2016-11-14 16:29 Jardiance® (empagliflozin) consistently reduced the risk of cardiovascular death in adults with type 2 diabetes regardless of the type of cardiovascular disease at baseline
2016-11-14 16:05 MetLife Hong Kong Promotes Hereditary Cancer Awareness with Sponsorship of Pink Heels Race 2016
2016-11-14 15:29 Masimo Receives Gates Foundation Grant to Develop Combined Pneumonia-Screening Device for High-Burden Settings
2016-11-14 10:19 Patient enrolment completed for RE-DUAL PCI™ study assessing dabigatran in atrial fibrillation patients after PCI with stenting
2016-11-11 16:23 Shiseido Wins the Poster Award at the 29th IFSCC Congress in Orlando
2016-11-09 11:04 Seattle Genetics and Takeda Complete Enrollment of Phase 3 ECHELON-2 Clinical Trial Evaluating ADCETRIS® (Brentuximab Vedotin) in Frontline Mature T-cell Lymphoma
2016-11-08 18:00 Bioventus Appoints Andrew McCartney Managing Director, International for EMEA
2016-11-08 17:01 New European study highlights differing priorities in physician’s therapy goals when treating advanced lung cancer patients
2016-11-08 15:39 Philips and Masimo Sign Multi-Year Business Partnership Agreement in Patient Monitoring and Select Therapy Solutions

Business Wire Weibo

Press Releases

Latest Releases